Daily Tech Wizard Newsletter

Stories / / By Daily Tech Wizard

Stryker invests $400M in CMR Surgical, with option to buy

Stryker puts $400M into a surgical robot maker, with an option to buy it.

Stryker has invested about $400 million in CMR Surgical, the Cambridge, U.K.-based maker of the Versius surgical robot, and has an option to buy the rest of the company.

The deal gives Stryker an exclusive option to acquire CMR's remaining equity, meaning it could eventually own 100%. It is subject to regulatory approvals and customary closing conditions.

Stryker also becomes the exclusive U.S. sales agent for the Versius portfolio. CMR keeps leading portfolio development and commercialization outside the United States.

CMR says it designed Versius to be compact and modular, so it doesn't require a dedicated OR. The robot supports general, colorectal, urology, gynecology and thoracic surgery. CMR says it has been adopted in more than 30 countries and used in 45,000 cases worldwide. Versius Plus has FDA 510(k) clearance for cholecystectomy, and CMR has filed a 510(k) submission for benign gynecological indications.

Andy Pierce, group president of medsurg and neurotechnology, called soft-tissue robotics a high-growth adjacency to Stryker's strengths in endoscopy and visualization. He said Stryker had evaluated the segment for years and picked Versius to help hospitals and ambulatory surgery centers grow robotic surgery across a broad range of procedures. Pierce will also join CMR's board. CEO Massimiliano Colella said the investment will help CMR accelerate innovation and the continued global expansion of Versius.

Would you be comfortable having a robot-assisted procedure?

Video: CMR Surgical on YouTube

Read the source: Reel: Stryker invests $400M into CMR Surgical (therobotreport.com)